Joseph Walter Vazzano - 22 Jan 2025 Form 4/A - Amendment Insider Report for Allarity Therapeutics, Inc. (ALLR)

Reporting relationship: Director
Issuer ticker: ALLR
Reported as of: 22 Jan 2025
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 24 Jan 2025, 20:10:53 UTC
Original report date: 24 Jan 2025
Prior SEC filing: 23 Jan 2025
Next SEC filing: 17 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph Vazzano

Key filing fact

Joseph Walter Vazzano filed Form 4/A - Amendment for Allarity Therapeutics, Inc. (ALLR) on 24 Jan 2025.

Key facts

This page summarizes Joseph Walter Vazzano's Form 4/A - Amendment filing for Allarity Therapeutics, Inc. (ALLR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jan 2025, 20:10.

Change

Previous filing in this sequence was filed on 23 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLR transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 22 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $1.01
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversary of the grant and are exercisable beginning as of that date.

SEC remarks

Form 4/A is being filed to correct errors in the original filing, where the expiration date was mistakenly reported as 01/22/2030, and the vesting date was incorrectly reported as the grant date.